Drs Katrina Bramstedt and Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.

IRBs must report human subject research protocol deviations and university leadership might also need to motivate compliance with federal regulations.

Transplant physicians must respect indecisive patients’ autonomy while continuing to educate them during their progress towards transplantation.

Key policy changes would better situate clinicians to prescribe care in ways that are ethical, safe, and effective.

Label analysis is key to educating patients about risks of vitamin A-containing supplements.

Increase in dietary supplement use in the United States suggests a great need for clinicians to be aware of the range of their quality parameters.

Weaknesses in regulatory approaches to negligent misrepresentation claims about dietary supplements can have clinical and public health consequences.

Consider the origins of America’s cosmetic and supplement industry and the advertising practices that sustain it.

Marissa Chaet Brykman joins Ethics Talk to discuss her article, coauthored with Dr Virginia Streusand Goldman, Dr Nandakumara Sarma, Dr Hellen A. Oketch-Rabah, Deborah Biswas and Dr Gabriel I. Giancaspro: “What Should Clinicians Know About Dietary Supplement Quality?”

Jorie Braunold joins Ethics Talk to discuss her article: “How Long Have Supplements Promised to Make Us Slim, Sexy, and Virile?”